The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
The Effects of Tibolone in Older Postmenopausal Women
Open accessAbstract
BACKGROUND: Tibolone has estrogenic, progestogenic, and androgenic effects. Although tibolone prevents bone loss, its effects on fractures, breast cancer, and cardiovascular disease are uncertain. METHODS: In this randomized study, we assigned 4538 women, who were between the ages of 60 and 85 years and had a bone mineral density T score of -2.5 or less at the hip or spine or a T score of -2.0 or less and radiologic evidence of a vertebral fracture, to receive once-daily tibolone (at a dose of 1.25 mg) or placebo. Annual spine radiographs were used to assess for vertebral fracture. Rates of cardiovascular events and breast cancer were adjudicated by expert panels. RESULTS: During a median of 34 months of treatment, the tibolone group, as compared with the placebo group, had a decreased risk of vertebral fracture, with 70 cases versus 126 cases per 1000 person-years (relative hazard, 0.55; 95% confidence interval [CI], 0.41 to 0.74; P<0.001), and a decreased risk of nonvertebral fracture, with 122 cases versus 166 cases per 1000 person-years (relative hazard, 0.74; 95% CI, 0.58 to 0.93; P=0.01). The tibolone group also had a decreased risk of invasive breast cancer (relative hazard, 0.32; 95% CI, 0.13 to 0.80; P=0.02) and colon cancer (relative hazard, 0.31; 95% CI, 0.10 to 0.96; P=0.04). However, the tibolone group had an increased risk of stroke (relative hazard, 2.19; 95% CI, 1.14 to 4.23; P=0.02), for which the study was stopped in February 2006 at the recommendation of the data and safety monitoring board. There were no significant differences in the risk of either coronary heart disease or venous thromboembolism between the two groups. CONCLUSIONS: Tibolone reduced the risk of fracture and breast cancer and possibly colon cancer but increased the risk of stroke in older women with osteoporosis. (ClinicalTrials.gov number, NCT00519857.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Fisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C. K., Kavanah, M., Cronin, W. M., Vogel, V., Robidoux, A., Dimitrov, N., Atkins, J., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.18.1371 · Cited by 5,485
Vertebral fracture assessment using a semiquantitative technique
Genant, H. K., Wu, C. Y., van Kuijk, C., & Nevitt, M. C. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650080915 · Cited by 3,691
Ettinger, B. (1999) · JAMA · doi:10.1001/jama.282.7.637 · Cited by 3,366
Self-citationBreast cancer and hormone-replacement therapy in the Million Women Study
(2003) · The Lancet · doi:10.1016/s0140-6736(03)14065-2 · Cited by 2,993
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310
Breast cancer and hormone-replacement therapy: the Million Women Study
Beral, V., Banks, E., Reeves, G., & Bull, D. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14596-5 · Cited by 1,273
Cauley, J. A. (2003) · JAMA · doi:10.1001/jama.290.13.1729 · Cited by 1,221
Stone, K. L., Seeley, D. G., Lui, L.-Y., Cauley, J. A., Ensrud, K., Browner, W. S., Nevitt, M. C., & Cummings, S. R. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.11.1947 · Cited by 1,051
Self-citationEffects of Raloxifene on Cardiovascular Events and Breast Cancer in Postmenopausal Women
Barrett-Connor, E., Mosca, L., Collins, P., Geiger, M. J., Grady, D., Kornitzer, M., McNabb, M. A., & Wenger, N. K. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062462 · Cited by 1,048
Self-citationOverview of the main outcomes in breast-cancer prevention trials
Cuzick, J., Powles, T., Veronesi, U., Forbes, J., Edwards, R., Ashley, S., & Boyle, P. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12342-2 · Cited by 965
Martino, S., Cauley, J. A., Barrett-Connor, E., Powles, T. J., Mershon, J., Disch, D., Secrest, R. J., Cummings, S. R., & For the CORE Investigators (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh319 · Cited by 684
Self-citationCauley, J. A., Norton, L., Lippman, M. E., Eckert, S., Krueger, K. A., Purdie, D. W., Farrerons, J., Karasik, A., Mellstrom, D., Ng, K. W., et al. (2001) · Breast Cancer Research and Treatment · doi:10.1023/a:1006478317173 · Cited by 678
Estrogen plus Progestin and Colorectal Cancer in Postmenopausal Women
Chlebowski, R. T., Wactawski-Wende, J., Ritenbaugh, C., Hubbell, F. A., Ascensao, J., Rodabough, R. J., Rosenberg, C. A., Taylor, V. M., Harris, R., Chen, C., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032071 · Cited by 669
Genant, H. K., Jergas, M., Palermo, L., Nevitt, M., Valentin, R. S., Black, D., & Cummings, S. R. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110716 · Cited by 643
Self-citationEndometrial cancer and hormone-replacement therapy in the Million Women Study
(2005) · The Lancet · doi:10.1016/s0140-6736(05)66455-0 · Cited by 613
Incidence of Invasive Breast Cancer by Hormone Receptor Status From 1992 to 1998
Li, C. I., Daling, J. R., & Malone, K. E. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.088 · Cited by 245
Laan, E. T. M., van Lunsen, R. H. W., & Everaerd, W. T. A. M. (2001) · Climacteric · doi:10.1080/713605033 · Cited by 200
Endogenous Testosterone Levels, Physical Performance, and Fall Risk in Older Men
Orwoll, E. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.19.2124 · Cited by 189
Tibolone: prevention of bone loss in late postmenopausal women
Bjarnason, N. H., Bjarnason, K., Haarbo, J., Rosenquist, C., & Christiansen, C. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.7.8675554 · Cited by 156
Self-citationPatel, V. A., & Sanyal, A. J. (2013) · Clinics in Liver Disease · doi:10.1016/j.cld.2013.07.012 · Cited by 152
Davison, S. L., & Davis, S. R. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021929 · Cited by 142
Gallagher, J. C., Baylink, D. J., Freeman, R., & McClung, M. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.10.7937 · Cited by 129
Receptor profiling and endocrine interactions of tibolone
de Gooyer, M. E., Deckers, G. H., Schoonen, W. G. E. J., Verheul, H. A. M., & Kloosterboer, H. J. (2002) · Steroids · doi:10.1016/s0039-128x(02)00112-5 · Cited by 128
Chetrite, G. S., Kloosterboer, H. J., & Pasqualini, J. R. (1997) · PubMed · Cited by 104
Stroke: Epidemiology, Clinical Picture, and Risk Factors
Tegos, T. J., Kalodiki, E., Daskalopoulou, S.-S., & Nicolaides, A. N. (2000) · Angiology · doi:10.1177/000331970005101001 · Cited by 103
Hormone replacement therapy use and variations in the risk of breast cancer
Opatrny, L., Dell’Aniello, S., Assouline, S. E., & Suissa, S. (2007) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2007.01520.x · Cited by 95
Sawaya, G. F., Grady, D., Kerlikowske, K. M., Valleur, J. L., Barnabei, V. M., Bass, K. M., Snyder, T. E., Pickar, J. H., Agarwal, S. K., & Js, M. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-12-200012190-00009 · Cited by 90
Effects of progestagens and Org OD14 in in vitro and in vivo tumor models
Kloosterboer, H. J., Schoonen, W. G. E. J., Deckers, G. H., & Klijn, J. G. M. (1994) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)90273-9 · Cited by 90
Banks, E., REEVES, G. K., Beral, V., Bull, D., Crossley, B., Simmonds, M., Hilton, E., Bailey, S., Barrett, N. K., Briers, P., et al. (2005) · Breast Cancer Research · doi:10.1186/bcr1364 · Cited by 85
Bots, M. L., Evans, G. W., Riley, W. A., McBride, K., Paskett, E. D., Helmond, F. A., & Grobbee, D. E. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi695 · Cited by 80
Self-citationFemale sexual dysfunction in postmenopausal women: Systematic review of placebo-controlled trials
Modelska, K., & Cummings, S. R. (2003) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2003.117 · Cited by 76
Self-citationPostmenopausal HRT and tibolone in relation to muscle strength and body composition
Jacobsen, D. E., Samson, M., Kežić, S., & Verhaar, H. J. J. (2007) · Maturitas · doi:10.1016/j.maturitas.2007.04.012 · Cited by 76
Stravitz, R. T., & Sanyal, A. J. (2003) · Clinics in Liver Disease · doi:10.1016/s1089-3261(03)00027-8 · Cited by 71
In vitro studies of tibolone in breast cells
Gompel, A., Chaouat, M., Jacob, D., Perrot, J., Kloosterboer, H. J., & Rostène, W. H. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(02)03203-x · Cited by 67
The effect of hormone replacement on physical performance in community-dwelling elderly women
Greenspan, S. L., Resnick, N. M., & Parker, R. A. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.03.004 · Cited by 62
Swanson, S. G., Drosman, S. R., Helmond, F. A., & Stathopoulos, V. M. (2006) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000247016.41007.c9 · Cited by 56
Self-citationConner, P., Christow, A., Kersemaekers, W. M., Söderqvist, G., Skoog, L. K., Carlström, K., Tani, E., Mol-Arts, M., & von Schoultz, B. (2004) · Climacteric · doi:10.1080/13697130310001651472 · Cited by 53
Self-citationTibolone Exerts Its Protective Effect on Trabecular Bone Loss Through the Estrogen Receptor
EDERVEEN, A. G. H., & Kloosterboer, H. J. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.9.1651 · Cited by 45
Gallagher, J. C. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.10.4717 · Cited by 44
A Primate Model of Human Postmenopausal Hot Flushes*
Jelínek, J., KAPPEN, A., Schönbaum, E., & Lomax, P. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-6-1224 · Cited by 37
A 55-Year-Old Woman With Osteopenia
Cummings, S. R. (2006) · JAMA · doi:10.1001/jama.296.21.2601 · Cited by 36
Self-citationThe influence of tibolone on quality of life in postmenopausal women
Meeuwsen, I. B., Samson, M., Duursma, S. A., & Verhaar, H. J. J. (2002) · Maturitas · doi:10.1016/s0378-5122(01)00251-1 · Cited by 29
Effects of two continuous hormone therapy regimens on C-reactive protein and homocysteine
Barnes, J. F., FARISH, E., Rankin, M., & Hart, D. M. (2005) · Menopause The Journal of The North American Menopause Society · doi:10.1097/00042192-200512010-00016 · Cited by 24
Effects of tibolone on human breast cancer cells and human vascular coronary cells
Mueck, A. O., Lippert, C., Seeger, H., et al. (2003) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-002-0291-x · Cited by 14
Lippert, C., Seeger, H., Wallwiener, D. R., & Mueck, A. O. (2002) · PubMed · Cited by 14
Cited by
Meschia, J. F., Bushnell, C., Boden-Albala, B., Braun, L. T., Bravata, D. M., Chaturvedi, S., Creager, M. A., Eckel, R. H., Elkind, M. S. V., Fornage, M., et al. (2014) · Stroke · doi:10.1161/str.0000000000000046 · Cited by 2,650
Goldstein, L. B., Bushnell, C. D., Adams, R. J., Appel, L. J., Braun, L. T., Chaturvedi, S., Creager, M. A., Culebras, A., Eckel, R. H., Hart, R. G., et al. (2011) · Stroke · doi:10.1161/str.0b013e3181fcb238 · Cited by 1,306
2016 IMS Recommendations on women’s midlife health and menopause hormone therapy
Baber, R. J., Panay, N., & Fenton, A. (2016) · Climacteric · doi:10.3109/13697137.2015.1129166 · Cited by 964
Treatment of symptoms of the menopause: an Endocrine Society Clinical Practice Guideline
Stuenkel, C. A., Davis, S. R., Gompel, A., Lumsden, M. A., Murad, M. H., Pinkerton, J. V., & Santen, R. J. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2236 · Cited by 884
Eastell, R., Rosen, C. J., Black, D. M., Cheung, A. M., Murad, M. H., & Shoback, D. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00221 · Cited by 868
Self-citation
Metadata
- Authors
- Cummings, S. R., Ettinger, B., Delmas, P. D., Kenemans, P., Stathopoulos, V., Verweij, P., Mol-Arts, M., Kloosterboer, L., Mosca, L., Christiansen, C., Bilezikian, J., Kerzberg, E. M., Johnson, S., Zanchetta, J., Grobbee, D. E., Seifert, W., & Eastell, R.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-08-14
- Volume
- 359
- Issue
- 7
- Pages
- 697-708
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2054376446
- Cited by
- 457
- References
- 48
- FWCI
- 33.12
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.